Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.

Author: Wanner, Christoph MD; Lachin, John M. ScD; Inzucchi, Silvio E. MD; Fitchett, David MD; Mattheus, Michaela Dipl Biomath; George, Jyothis MBBS, PhD, FRCP; Woerle, Hans J. MD; Broedl, Uli C. MD; von Eynatten, Maximilian MD; Zinman, Bernard MD; On behalf of the EMPA-REG OUTCOME Investigators

Page: 119-129

http://ift.tt/2ma64a8